Form 8-K · Current report
BNY Mellon 8-K, filed Aug 12, 2026
- Filed
- CIK
- 0001390777
- Accession no.
- 0001193125-26-347061
Summary
The Bank of New York Mellon Corporation issued $2.5 billion in senior medium-term notes: $300 million of floating-rate callable notes due 2030, $1.2 billion of 4.755% fixed-to-floating callable notes due 2030, and $1 billion of 5.182% fixed-to-floating callable notes due 2034. The notes were registered under a Form S-3 shelf registration statement, with Sullivan & Cromwell LLP providing the validity opinion.
Key points
- The notes comprise $300 million floating rate callable notes due 2030, $1.2 billion 4.755% fixed/floating callable notes due 2030, and $1 billion 5.182% fixed/floating callable notes due 2034.
- The issuance was registered under a Form S-3 registration statement (File No. 333-282710).
- Sullivan & Cromwell LLP's opinion and consent were filed as Exhibits 5.1 and 23.1.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
ITEM 8.01. OTHER EVENTS. On August 12, 2026, The Bank of New York Mellon Corporation issued $300,000,000 aggregate principal amount of its Floating Rate Callable Senior Medium-Term Notes Series J due 2030 (the “2030 Floating Rate Notes”), $1,200,000,000 aggregate principal amount of its 4.755% Fixed Rate / Floating Rate Callable Senior Medium-Term Notes Series J due 2030 (the “2030 Fixed Rate / Floating Rate Notes”) and $1,000,000,000 aggregate principal amount of its 5.182% Fixed Rate / Floating Rate Callable Senior Medium-Term Notes Series J due 2034 (the “2034 Fixed Rate / Floating Rate Notes” and, together with the 2030 Floating Rate Notes and the 2030 Fixed Rate / Floating Rate Notes…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.